SWX:ABBN
SWX:ABBNElectrical

How Investors Are Reacting To ABB (SWX:ABBN) Expanding Australian Smart Building Reach With Qantec Alliance

Qantec Automation has announced a new alliance with ABB to deliver open, sustainable smart building and IoT automation solutions across Australia, combining ABB’s building technologies with Qantec’s local market expertise. This collaboration highlights how ABB is using local distribution partnerships to deepen its presence in the smart building segment and support more efficient, lower‑emission infrastructure. We’ll now explore how ABB’s expanded Australian smart building footprint with...
SWX:UBSG
SWX:UBSGCapital Markets

Is UBS Group (SWX:UBSG) Still Attractive After The Credit Suisse Integration And Strong Share Gains

If you are trying to work out whether UBS Group at about CHF 37.95 is still offering value or starting to look stretched, you are in the right place. The stock has returned 1.0% over the last 7 days, 10.5% over the last 30 days, 33.4% over the last year and very large gains over 3 and 5 years, while the year to date return sits at a 0.6% decline. Recent attention on UBS Group has been shaped by its integration of Credit Suisse and its evolving role as a major global wealth manager. These...
SWX:NWRN
SWX:NWRNPharmaceuticals

3 European Growth Stocks With Up To 31% Insider Ownership

As European markets continue to show optimism, with the pan-European STOXX Europe 600 Index rising by 2.27% amid positive economic signals and company earnings, investors are keenly observing growth companies that demonstrate strong insider ownership. In this environment, stocks with significant insider stakes can be appealing as they often indicate confidence from those closest to the company's operations and strategy.
SWX:UBSG
SWX:UBSGCapital Markets

Assessing UBS Group (SWX:UBSG) Valuation After Trading Momentum And Upcoming Earnings Focus

UBS Group (SWX:UBSG) is drawing fresh attention after a 1.57% intraday move on elevated volume, with traders eyeing the 4 February 2026 earnings announcement and recent recognition for a UBS wealth team on Forbes' national ranking. See our latest analysis for UBS Group. The latest move sits on top of a strong run, with a 30 day share price return of 11.13% and a 90 day gain of 17.46%. Total shareholder return over five years is 224.14%, suggesting momentum has been building even as traders...
SWX:LOGN
SWX:LOGNTech

Is Logitech International (SWX:LOGN) Pricing Look Interesting After Recent 19.1% Monthly Share Decline

If you are wondering whether Logitech International shares are priced attractively right now, this article walks through what the current market price might be implying about the company. The stock closed at $77.34, with returns of 0.2% over 1 year, a 19.1% decline over 30 days, a 5.2% decline over 7 days, and a 2.7% decline year to date. This may signal shifting expectations around its future prospects and risk profile. Recent market commentary has focused on Logitech International as...
SWX:SOON
SWX:SOONMedical Equipment

Assessing Sonova Holding (SWX:SOON) Valuation After Recent Share Price Stabilisation

Sonova Holding (SWX:SOON) has drawn investor attention after recent performance data showed a 5.9% return over the past month, alongside a 2.2% move over the past week and a 0.1% gain in the latest session. See our latest analysis for Sonova Holding. Those recent share price gains come after a weaker patch, with the 90 day share price return at a 2.76% decline and the 1 year total shareholder return at a 28.9% loss. This suggests short term momentum is picking up while longer term holders are...
SWX:NOVN
SWX:NOVNPharmaceuticals

Is Novartis (SWX:NOVN) Pricing Reflect Its Strong Multi‑Year Share Price Performance?

If you are wondering whether Novartis shares are still reasonably priced or already baking in a lot of good news, you are in the right place. The stock last closed at US$113.76, with returns of 3.8% over 7 days, 6.5% over 30 days, 4.8% year to date, 28.6% over 1 year, 59.9% over 3 years and 74.2% over 5 years. This performance has caught the attention of many long term holders and potential new investors. Recent news around Novartis has focused on ongoing product pipeline updates and...